Effect of 24 hour fast in obese children

Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|September 30, 1976
PubMed

Insights

Fasting in obese children reveals reduced fat mobilization and increased branched-chain amino acids, suggesting peripheral insulin resistance. These findings highlight key metabolic differences in childhood obesity.

Area of Science:

  • Pediatrics
  • Metabolic Research
  • Endocrinology

Background:

  • Childhood obesity is a growing health concern with complex metabolic underpinnings.
  • Understanding metabolic responses to fasting in obese children is crucial for developing effective interventions.

Purpose of the Study:

  • To investigate the metabolic effects of a 24-hour fast in obese children compared to healthy controls.
  • To identify potential biomarkers and physiological differences associated with obesity in pediatric populations.

Main Methods:

  • A 24-hour fasting study was conducted on 21 obese children (aged 7-14) and 8 healthy controls.
  • Measurements included blood glucose, plasma cortisol, free fatty acids (FFA), ketonuria, serum alanine, and branched-chain amino acids.
  • Glucagon stimulation tests were performed before and after the fast.

Main Results:

  • Obese children showed a less pronounced drop in blood glucose and higher post-fast ketonuria compared to controls.
  • While FFA increased in both groups, levels were lower in obese children, indicating reduced fat mobilization.
  • Obese children exhibited a significant rise in branched-chain amino acids and demonstrated peripheral insulin resistance, evidenced by hyperinsulinism during glucagon tests.

Conclusions:

  • Childhood obesity is characterized by impaired fat mobilization and altered amino acid metabolism during fasting.
  • Peripheral insulin resistance is a key feature in obese children, even with normal protein gluconeogenesis.
  • These metabolic differences may represent a significant biological characteristic of pediatric obesity.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
3.1K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.5K